These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


142 related items for PubMed ID: 9866789

  • 1. Lymphoproliferative disorders after renal transplantation: role of medical imaging.
    Claudon M, Kessler M, Champigneulle J, Lefevre F, Hestin D, Renoult E.
    Eur Radiol; 1998; 8(9):1686-93. PubMed ID: 9866789
    [Abstract] [Full Text] [Related]

  • 2. Posttransplantation lymphoproliferative disorder: changing manifestations of disease in a renal transplant population.
    Miller WT, Siegel SG, Montone KT.
    Crit Rev Diagn Imaging; 1997 Dec; 38(6):569-85. PubMed ID: 9442979
    [Abstract] [Full Text] [Related]

  • 3. Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients.
    Libertiny G, Watson CJ, Gray DW, Welsh KI, Morris PJ.
    Br J Surg; 2001 Oct; 88(10):1330-4. PubMed ID: 11578286
    [Abstract] [Full Text] [Related]

  • 4. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M, Badwal S, Pandey R, Srivastava A, Sharma RK, Gupta RK.
    Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
    [Abstract] [Full Text] [Related]

  • 5. Posttransplantation lymphoproliferative disorder in a renal allograft recipient.
    Goral S, Felgar R, Shappell S.
    Am J Kidney Dis; 1997 Aug; 30(2):301-7. PubMed ID: 9261047
    [Abstract] [Full Text] [Related]

  • 6. Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report.
    Miyagi S, Sekiguchi S, Kawagishi N, Akamatsu Y, Satoh K, Takeda I, Fukushima D, Kobayashi Y, Tokodai K, Fujimori K, Satomi S.
    Transplant Proc; 2011 Nov; 43(9):3299-301. PubMed ID: 22099782
    [Abstract] [Full Text] [Related]

  • 7. Postransplant lymphoproliferative disorder localized near the allograft in renal transplantation.
    Kew CE, Lopez-Ben R, Smith JK, Robbin ML, Cook WJ, Gaston RS, Deierhoi MH, Julian BA.
    Transplantation; 2000 Mar 15; 69(5):809-14. PubMed ID: 10755531
    [Abstract] [Full Text] [Related]

  • 8. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S, Zafar MN, Best J, Reddy HK.
    J Cardiovasc Pharmacol Ther; 2006 Mar 15; 11(1):77-83. PubMed ID: 16703222
    [Abstract] [Full Text] [Related]

  • 9. Post-transplant Lymphoproliferative Disorder in a Patient After Kidney Transplant, 5-Year Follow-up: A Case Report.
    Ignacak E, Sułowicz J, Giza A, Cieniawski D, Kuźniewski M, Sułowicz W.
    Transplant Proc; 2020 Oct 15; 52(8):2517-2519. PubMed ID: 32222386
    [Abstract] [Full Text] [Related]

  • 10. Acute renal allograft rejection in patients with Epstein-Barr virus associated post-transplant lymphoproliferative disorder.
    Purighalla R, Shapiro R, Jordan ML, Scantlebury VP, Gritsch HA, Vivas C, Randhawa PS.
    Clin Transplant; 1997 Dec 15; 11(6):574-6. PubMed ID: 9408687
    [Abstract] [Full Text] [Related]

  • 11. [Lymphoproliferative disorders after renal transplantation in a child].
    Márquez U S, Peredo G MS, Vogel S A, Ibáñez A P.
    Rev Med Chil; 2009 Mar 15; 137(3):405-10. PubMed ID: 19621184
    [Abstract] [Full Text] [Related]

  • 12. Post-transplantation lymphoproliferative disorder: the spectrum of imaging appearances.
    Scarsbrook AF, Warakaulle DR, Dattani M, Traill Z.
    Clin Radiol; 2005 Jan 15; 60(1):47-55. PubMed ID: 15642292
    [Abstract] [Full Text] [Related]

  • 13. Cessation of immunosuppression during chemotherapy for post-transplant lymphoproliferative disorders in renal transplant patients.
    Taylor E, Jones M, Hourigan MJ, Johnson DW, Gill DS, Isbel N, Hawley CM, Marlton P, Gandhi MK, Campbell SB, Mollee P.
    Nephrol Dial Transplant; 2015 Oct 15; 30(10):1774-9. PubMed ID: 26188340
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hepatitis C virus related lymphoproliferative disorder in a renal transplant recipient.
    Aravindan AN, Moger V, Sakhuja V, Kohli HS, Varma N, Jha V.
    Int Urol Nephrol; 2006 Oct 15; 38(2):355-7. PubMed ID: 16868710
    [Abstract] [Full Text] [Related]

  • 16. Imaging features of posttransplantation lymphoproliferative disorder in pancreas transplant recipients.
    Meador TL, Krebs TL, Cheong JJ, Daly B, Keay S, Bartlett S.
    AJR Am J Roentgenol; 2000 Jan 15; 174(1):121-4. PubMed ID: 10628466
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term survival after post-transplant lymphoproliferative disease in children.
    Nathanson S, Debray D, Delarue A, Deschênes G.
    Pediatr Nephrol; 2002 Aug 15; 17(8):668-72. PubMed ID: 12185479
    [Abstract] [Full Text] [Related]

  • 20. Native kidney posttransplant lymphoproliferative disorder in a renal transplant recipient.
    Chandra A, Kaul A, Aggarwal V, Srivastava D.
    Saudi J Kidney Dis Transpl; 2017 Aug 15; 28(4):942-944. PubMed ID: 28748904
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.